Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BMY compared with MRK: revenue, margins and what each company keeps, and the suppliers and customers both name
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
MRK
Merck & Co., Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BMY
Bristol Myers Squibb Co
vs
MRK
Merck & Co., Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
MRK
1 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±3.4%
▲
+3.83%
×1.12
Q2 FY26
±4.1%
▲
+0.18%
×0.05
= implied
BMY realized, solid
MRK realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±3.9%
▼
−1.60%
×0.41
Feb 3 '26
±4.3%
▲
+2.18%
×0.51
BMY
Bristol Myers Squibb Co
Change
63.03
· pre 62.46
· delayed
Mkt cap
$127.7B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
MRK
Merck & Co., Inc.
Change
148.44
· pre 147.39
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$366.0B
Revenue
$16.6B
Q2 FY26
Revenue
$65.0B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
BMY
Bristol Myers Squibb Co
vs
MRK
Merck & Co., Inc.
63.03
pre 62.46
delayed
Price
148.44
pre 147.39
delayed
$127.7B
Mkt cap
$366.0B
Q3 FY26
$13.1B
Revenue
$16.6B
Q2 FY26
FY25
$48.2B
Revenue
$65.0B
FY25
Change
Change
BMY
63.03
vs
MRK
148.44
Pre-market
Nov 3 '26
delayed